Peregrine Pharmaceuticals
NASDAQ: PPHM
$4.22
+$0.03 (+0.7%)
Closing price January 5, 2018
PPHM Articles
Stocks are up Tuesday, with the Dow Jones Industrial Average up 0.39%, the Nasdaq up 0.36% and the S&P 500 up 0.35%. Tuesday’s sole winner is in correction, while today’s losers include an...
Published:
Last Updated:
The three major U.S. stock indexes opened lower this morning following weak economic data from Germany (more coverage here). The weekend meetings between Chancellor Angela Merkel and French President...
Published:
Last Updated:
Source: Photo by Spencer Platt/Getty ImagesThe stock market is down Monday, with the Dow Jones Industrial Average down 0.13%, the Nasdaq down 0.50% and the S&P 500 down 0.18%. Monday’s winners...
Published:
Last Updated:
Just over two weeks ago Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) reported a statistically significant improvement in the company’s bavituximab lung-cancer treatment. Shares jumped nearly 50%...
Published:
The three major U.S. stock indexes opened lower this morning after a weekend of mixed news from Asia. China’s trade balance rose on falling imports and industrial production failed to meet...
Published:
Last Updated:
The three major U.S. stock indexes opened mixed this morning following a lower-than-expected increase in non-farm payrolls (more coverage here). In Asia and Europe, though, markets were higher for...
Published:
Last Updated:
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) is surging on news updating its non-small cell lung cancer trial. The company said that interim results were presented from its 121 patient randomized,...
Published:
Last Updated:
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend.  This is broken down...
Published:
We are just about to get the first round of abstracts from companies presenting data at this year’s American Society of Clinical Oncology meeting for 2009. At BioHealthInvestor.com we...
Published:
Alkermes (NASDAQ: ALKS) and Johnson & Johnson Pharmaceutical Research and Developed today submitted paperwork seeking approval of their partnership drug, RISPERDAL CONSTA, to be allowed for...
Published:
Bearingpoint (BE) Still dropping after loss earlier in the month. Down to $2.53 from 52-week $8.56. General Growth Properties (GGP) REIT stocks are getting killed. Falls to $41.93 from 52-week high...
Published:
Last Updated:
Novastar Finl Inc (NFI) Poor earnings and possible delisting. Drops to $1.72 from 52-week high of $127.20. Standard Pacific (SPF) Home builder. Down to $3.66 from 52-week high of $30.52. Fannie...
Published:
Last Updated:
Dell (DELL) got another delisting warning yesterday. It has to file its financials on time, or risk being thrown off the exchange. Dell has gotten a number of these. but Nasdaq (NDAQ) keeps pushing...
Published:
Blackstone (BX) Investors still worry about slowing private equity and tax issues. Shares fall to $28.75 from post-IPO high of $38. American Home Mtg (AHM) Forecasts second quarter loss on delinquent...
Published: